Furthermore, in all three different FSGS models (miR-193a, Actn4 KO, Cd2ap+/-;Fyn-/-) classical podocyte marker genes did not appear strongly changed, with the exception of respective model-specific, disease-causing alterations. This evidence concerns the gene CD2AP and focal segmental glomerulosclerosis.